Document is current
Any future updates will be listed below
-
Authors
Yazici, Yusuf
Hatemi, Gulen
- License Information
-
More Information
Article History
Received: 17 November 2025
Accepted: 17 March 2026
First Online: 24 March 2026
Declarations
:
: The authors declare no competing interests.
: Y Yazici: Consultant: Amgen, Chugai, Soligenix, argenx, Hemay. G Hatemi: Consultant: Bayer, Celgene, Johnson&Johnson. Expert testimony: Deva Pharmaceuticals. Grants: Celgene, Amgen, Lilly. Honoraria: UCB Pharma. Development of educational content: AbbVie, Boehringer Ingelheim, Novartis, UCB Pharma.
: This article is a review article and does not contain any new studies with human or animal subjects performed by any of the authors.
